Pregled bibliografske jedinice broj: 1250592
Synbiotics in the Management of Pediatric Gastrointestinal Disorders: Position Paper of the ESPGHAN Special Interest Group on Gut Microbiota and Modifications
Synbiotics in the Management of Pediatric Gastrointestinal Disorders: Position Paper of the ESPGHAN Special Interest Group on Gut Microbiota and Modifications // Journal of pediatric gastroenterology and nutrition, 76 (2022), 1; 102-108 doi:10.1097/mpg.0000000000003568 (međunarodna recenzija, članak, stručni)
CROSBI ID: 1250592 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Synbiotics in the Management of Pediatric
Gastrointestinal Disorders: Position Paper of the
ESPGHAN Special Interest Group on Gut Microbiota
and Modifications
Autori
Hojsak, Iva ; Kolaček, Sanja ; Mihatsch, Walter ; Mosca, Alexis ; Shamir, Raanan ; Szajewska, Hania ; Vandenplas, Yvan
Kolaboracija
Working Group on Probiotics and Prebiotics of the European Society for Paediatric Gastroenterology ; Hepatology and Nutrition ;
Izvornik
Journal of pediatric gastroenterology and nutrition (0277-2116) 76
(2022), 1;
102-108
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, stručni
Ključne riječi
synbiotics
Sažetak
Background: Synbiotics are a mixture comprising of live microorganisms and substrate(s) selectively utilized by host microorganisms that confers a health benefit on the host. There is an increasing number of studies investigating their role in different diseases and disorders. Aim: The purpose of this article is to provide recommendations for the use of synbiotics in the management of pediatric gastrointestinal disorders. The recommendations are developed by the ESPGHAN Special Interest Group on Gut Microbiota and Modifications. Methods: From existing literature databases, we searched and appraised all systematic reviews and/or meta-analyses, and subsequently published randomized controlled trials (RCTs) that compared the use of synbiotics, in all delivery vehicles and formulations, at any dose, compared to no synbiotics. Synbiotics which are part of infant formula were not assessed. The recommendations were formulated only if at least 2 RCTs that used a well-defined synbiotic were available. Results: Based on the currently available evidence, no recommendation can be formulated in favor or against the use of evaluated synbiotic combination in the treatment of acute gastroenteritis, prevention of necrotizing enterocolitis, Helicobacter pylori infection, inflammatory bowel disease, functional gastrointestinal disorders, and allergy in infants and children. Conclusions: There is a need for more, well- designed RCTs on the role of synbiotics in gastrointestinal disorders with the same outcome measures to enable the inter-studies comparisons.
Izvorni jezik
Engleski
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb,
Klinika za dječje bolesti
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE